Jason C. Jones - 06 Jan 2026 Form 4 Insider Report for EKSO BIONICS HOLDINGS, INC. (EKSO)

Signature
/s/ Jerome Wong
Issuer symbol
EKSO
Transactions as of
06 Jan 2026
Net transactions value
-$12,210
Form type
4
Filing time
07 Jan 2026, 16:45:57 UTC
Previous filing
10 Dec 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Jones Jason C Chief Operating Officer 101 GLACIER POINT, SUITE A, SAN RAFAEL /s/ Jerome Wong 07 Jan 2026 0001775619

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EKSO Common Stock Sale $12,210 -1,320 -4.9% $9.25 25,621 06 Jan 2026 Direct F1, F2, F3
holding EKSO Common Stock 3,141 06 Jan 2026 By 401(k) F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares sold by the Reporting Person on January 6, 2026 to cover tax withholding obligations incurred upon the vesting and settlement of restricted stock awards originally reported by the Reporting Person in a Form 4 filed with the Commission on June 15, 2023.
F2 These shares were sold in a single transaction at a price of $9.25 per share.
F3 On June 2, 2025, the Issuer effected a 1-for-15 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split.